Literature DB >> 11002759

HTLV-1 infections.

C R Bangham1.   

Abstract

Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or prognosis in infected people. Recent research on the molecular virology and immunology of HTLV-1 shows the importance of the host's immune response in reducing the risk of these diseases, and is beginning to explain why some HTLV-1 infected people develop serious illnesses whereas most remain healthy life long carriers of the virus. These findings might be applicable to other persistent virus infections such as human immunodeficiency virus, hepatitis B, and hepatitis C.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11002759      PMCID： PMC1762938          DOI： 10.1136/jcp.53.8.581

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  70 in total

1.  Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.

Authors:  J Kira; Y Koyanagi; T Yamada; Y Itoyama; I Goto; N Yamamoto; H Sasaki; Y Sakaki
Journal:  Ann Neurol       Date:  1991-02       Impact factor: 10.422

2.  The effect of zidovudine on chronic myelopathy associated with HTLV-1.

Authors:  O Gout; A Gessain; M Iba-Zizen; S Kouzan; F Bolgert; G de Thé; O Lyon-Caen
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

3.  Variation in the clinical courses of adult T-cell leukemia.

Authors:  F Kawano; K Yamaguchi; H Nishimura; H Tsuda; K Takatsuki
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

4.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

5.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

Authors:  M Yoshida; M Seiki; K Yamaguchi; K Takatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.

Authors:  K Okochi; H Sato; Y Hinuma
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

7.  Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells.

Authors:  P Höllsberg; K W Wucherpfennig; L J Ausubel; V Calvo; B E Bierer; D A Hafler
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

8.  Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

Authors:  M Shimoyama
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

9.  Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol.

Authors:  W J Harrington; W A Sheremata; S R Snodgrass; S Emerson; S Phillips; J R Berger
Journal:  AIDS Res Hum Retroviruses       Date:  1991-12       Impact factor: 2.205

10.  HTLV-I uveitis: a distinct clinical entity caused by HTLV-I.

Authors:  M Mochizuki; T Watanabe; K Yamaguchi; K Takatsuki; K Yoshimura; M Shirao; S Nakashima; S Mori; S Araki; N Miyata
Journal:  Jpn J Cancer Res       Date:  1992-03
View more
  27 in total

1.  Acute pancreatitis induced by diffuse pancreatic invasion of adult T-cell leukemia/lymphoma cells.

Authors:  Akinori Mori; Yasuharu Kikuchi; Shigeatsu Motoori; Jun'ichiro Watanabe; Masami Shinozaki; Masanobu Eguchi
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

Review 2.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

3.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

4.  Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

Authors:  William Johnson; Anjali Mishra; Adam Binder; Alejandro Gru; Pierluigi Porcu
Journal:  Haematologica       Date:  2019-05       Impact factor: 9.941

5.  Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells.

Authors:  Wei Ding; Björn Albrecht; Robert E Kelley; Natarajan Muthusamy; Seung-Jae Kim; Ruth A Altschuld; Michael D Lairmore
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation.

Authors:  Wei Ding; Seung-Jae Kim; Amrithraj M Nair; Bindhu Michael; Kathleen Boris-Lawrie; Adam Tripp; Gerold Feuer; Michael D Lairmore
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Isolation and confirmation of human T-cell leukemia virus type 2 from peripheral blood mononuclear cells.

Authors:  Michael D Lairmore; Andy Montgomery
Journal:  Methods Mol Biol       Date:  2005

Review 8.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 9.  Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.

Authors:  Michael Bindhu; Amrithraj Nair; Michael D Lairmore
Journal:  Front Biosci       Date:  2004-09-01

10.  Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.

Authors:  Michael S Mitchell; Ellen T Bodine; Shawn Hill; Gerald Princler; Patricia Lloyd; Hiroaki Mitsuya; Masao Matsuoka; David Derse
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.